Company No: 12307768 (England and Wales)

Contents

• Balance Sheet
• Notes to the Financial Statements

	Note	2025		2024
		£		£
Fixed assets
Tangible assets	3	519		808
		519		808
Current assets
Debtors	4	33,659		33,829
Cash at bank and in hand		251		5,056
		33,910		38,885
Creditors: amounts falling due within one year	5	( 32,853)		( 32,972)
Net current assets		1,057		5,913
Total assets less current liabilities		1,576		6,721
Net assets		1,576		6,721
Capital and reserves
Called-up share capital	6	1		1
Profit and loss account		1,575		6,720
Total shareholders' funds		1,576		6,721

For the financial year ending 31 August 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Statement of Income and Retained Earnings has not been delivered.

The financial statements of Thrivebiomedica Limited (registered number: 12307768) were approved and authorised for issue by the Board of Directors on 29 May 2026. They were signed on its behalf by:

Mr G J Remfry Director

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Thrivebiomedica Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 44 Buckingham Road, Shoreham-By-Sea, BN43 5UD, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer.
Revenue from services is recognised as they are delivered.

Taxation

Current tax
Current tax is provided at amounts expected to be paid using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a basis over its expected useful life, as follows:

Office equipment

3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

2. Employees

	2025		2024
	Number		Number
Monthly average number of persons employed by the Company during the year, including directors	2		2

3. Tangible assets

	Office equipment		Total
	£		£
Cost
At 01 September 2024	1,868		1,868
At 31 August 2025	1,868		1,868
Accumulated depreciation
At 01 September 2024	1,060		1,060
Charge for the financial year	289		289
At 31 August 2025	1,349		1,349
Net book value
At 31 August 2025	519		519
At 31 August 2024	808		808

4. Debtors

	2025		2024
	£		£
Other debtors	33,659		33,829

5. Creditors: amounts falling due within one year

	2025		2024
	£		£
Corporation tax	30,368		27,922
Other taxation and social security	335		3,250
Other creditors	2,150		1,800
	32,853		32,972

6. Called-up share capital

	2025		2024
	£		£
Allotted, called-up and fully-paid
2 Ordinary shares of £ 0.50 each	1		1

7. Related party transactions

Transactions with owners holding a participating interest in the entity

	2025		2024
	£		£
Key management	31,483		33,829

Interest has been charged on the directors loan account as per HMRC rates.